Pfs Partners, LLC Pfizer Inc Transaction History

Pfs Partners, LLC

$161 Billion
Q2 2024

A detailed history of Pfs Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Pfs Partners, LLC holds 4,130 shares of PFE stock, worth $117,539. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,130

Previous 4,106 0.58%

Holding current value

$117,539

Previous $114 Million 1.42%

% of portfolio

0.07%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $606 - $710	24 Added 0.58%	4,130 $116 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $9,889 - $11,356	382 Added 10.26%	4,106 $114 Million
Q4 2023 Jan 26, 2024	BUY	$26.13 - $33.94 $20,982 - $27,253	803 Added 27.49%	3,724 $107 Million
Q3 2023 Nov 30, 2023	BUY	$32.09 - $37.51 $352 - $412	11 Added 0.38%	2,921 $96.9 Million
Q2 2023 Nov 30, 2023	BUY	$36.12 - $41.79 $325 - $376	9 Added 0.31%	2,910 $107 Million
Q1 2023 Nov 30, 2023	BUY	$39.39 - $51.28 $10,123 - $13,178	257 Added 9.72%	2,901 $118 Million
Q4 2022 Nov 30, 2023	BUY	$41.75 - $54.5 $7,097 - $9,265	170 Added 6.87%	2,644 $135 Million
Q3 2022 Nov 30, 2023	SELL	$43.76 - $53.42 $89,226 - $108,923	-2,039 Reduced 45.18%	2,474 $108 Million
Q2 2022 Nov 30, 2023	SELL	$46.53 - $55.17 $9,119 - $10,813	-196 Reduced 4.16%	4,513 $237 Million
Q1 2022 Nov 30, 2023	BUY	$45.75 - $56.69 $17,430 - $21,598	381 Added 8.8%	4,709 $244 Million
Q4 2021 Nov 30, 2023	BUY	$41.32 - $61.25 $178,832 - $265,090	4,328 New	4,328 $256 Million

Others Institutions Holding PFE

# of Institutions

3,231

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.

Account